Gene: TNXB

7148
EDS3|EDSCLL|HXBL|TENX|TN-X|TNX|TNXB1|TNXB2|TNXBS|VUR8|XB|XBS
tenascin XB
protein-coding
6p21.33-p21.32
Ensembl:ENSG00000168477 MIM:600985 Vega:OTTHUMG00000031088 UniprotKB:P22105
NG_008337.2
PubMed|SNP Mapped
ND|AD
2   
NA (AD)  NA (ND)   (Frontal_Cortex)
NA (AD)  NA (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs2071293chr6:32094910 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)
rs7766862chr6:32065230 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg04872123chr6:32049699TNXBGene body2.054e-4Alcohol use disorders26763658
cg26872482chr6:32051108TNXBGene body4.563e-4Alcohol use disorders26763658
cg27337194chr6:32036911TNXB7.720e-8Maternal smoking in pregnancy27040690
cg06580770chr6:32054790TNXB7.100e-8Smoking27651444

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
EPB410.804
LAMA50.784
NBEAL20.747
MED120.738
PIAS30.723
UBR40.721
MAP3K30.716
PHKA20.713
EP4000.713
ZZEF10.71

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
TSPAN8-0.315
OR4F5-0.3
OR4F29-0.299
UTS2-0.28
GSDMC-0.267
FXYD4-0.265
SH2D1A-0.259
SPRR2E-0.257
HOXD1-0.257
CTNNA3-0.254

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
D000082AcetaminophenAcetaminophen results in decreased expression of TNXB mRNA29067470
D020106AcrylamideAcrylamide results in decreased expression of TNXB mRNA28959563
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of TNXB mRNA21641981
D000643Ammonium ChlorideAmmonium Chloride affects the expression of TNXB mRNA16483693
D000968Antimycin AAntimycin A results in decreased expression of TNXB mRNA19304788
D018501Antirheumatic AgentsAntirheumatic Agents results in increased expression of TNXB mRNA24449571
D001151ArsenicArsenic affects the methylation of TNXB gene25304211
C006703benzo(b)fluoranthenebenzo(b)fluoranthene results in increased expression of TNXB mRNA26377693
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of TNXB mRNA22300585
C543008bis(4-hydroxyphenyl)sulfone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TNXB mRNA28628672
C006780bisphenol Abisphenol A affects the expression of TNXB mRNA25181051
C000611646bisphenol F[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TNXB mRNA28628672
D002251Carbon TetrachlorideCarbon Tetrachloride affects the expression of TNXB mRNA17484886
D002392Catechin[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of TNXB mRNA24763279
C031180chrysenechrysene results in increased expression of TNXB mRNA26377693
C480342clothianidinclothianidin results in decreased expression of TNXB mRNA29044138
D003300Copper[NSC 689534 binds to Copper] which results in increased expression of TNXB mRNA20971185
D019327Copper SulfateCopper Sulfate results in increased expression of TNXB mRNA19549813
D016572CyclosporineCyclosporine results in decreased methylation of TNXB promoter27989131
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TNXB mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TNXB mRNA28628672
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of TNXB mRNA28628672
C016366dibenzothiophenedibenzothiophene results in decreased expression of TNXB mRNA23656968
C574336excavatolide Bexcavatolide B results in increased expression of TNXB protein26790859
C010974glyphosateglyphosate results in decreased expression of TNXB mRNA28711546
C511402Grape Seed Proanthocyanidins[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of TNXB mRNA24763279
D006540HerbicidesHerbicides results in decreased expression of TNXB mRNA28711546
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TNXB mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TNXB mRNA28628672
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of TNXB mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of TNXB mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TNXB mRNA28628672
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of TNXB mRNA28628672
D007840LatexLatex analog results in decreased expression of TNXB mRNA24768652
D008727MethotrexateMethotrexate results in increased expression of TNXB mRNA24449571
C016599mono-(2-ethylhexyl)phthalatemono-(2-ethylhexyl)phthalate results in decreased expression of TNXB mRNA22401849
D009151Mustard GasMustard Gas results in decreased expression of TNXB mRNA18988085
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of TNXB mRNA"25554681|2562005
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of TNXB mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of TNXB mRNA"25620056
C558013NSC 689534[NSC 689534 binds to Copper] which results in increased expression of TNXB mRNA20971185
D010100OxygenOxygen deficiency results in increased expression of TNXB mRNA26516004
C084656paricalcitol[Phosphorus co-treated with paricalcitol] results in increased expression of TNXB mRNA17715259
D010758Phosphorus[Phosphorus co-treated with paricalcitol] results in increased expression of TNXB mRNA17715259
D010936Plant ExtractsPlant Extracts results in decreased expression of TNXB mRNA23557933
D011441PropylthiouracilPropylthiouracil results in decreased expression of TNXB mRNA24780913
C043680ptaquilosideptaquiloside results in decreased expression of TNXB mRNA23274088
D015474IsotretinoinIsotretinoin results in increased expression of TNXB mRNA20436886
D012402RotenoneRotenone results in decreased expression of TNXB mRNA19304788
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of TNXB mRNA25895662
C017947sodium arsenitesodium arsenite results in increased methylation of TNXB gene24570342
D018038Sodium SeleniteSodium Selenite results in decreased expression of TNXB mRNA23274088
D053260SootSoot results in decreased expression of TNXB mRNA26551751
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of TNXB mRNA21998131
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of TNXB mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of TNXB protein27105554
C009495titanium dioxidetitanium dioxide results in decreased expression of TNXB mRNA23557971|2776080
C015559trimellitic anhydridetrimellitic anhydride results in decreased expression of TNXB mRNA19042947
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of TNXB mRNA"26179874
D024483Vitamin K 3Vitamin K 3 affects the expression of TNXB mRNA20044591

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005178integrin binding-ISS-  
GO:0005515protein binding-IPI21516116  25416956  
GO:0008201heparin binding-ISS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0007155cell adhesion-ISS-  
GO:0030036actin cytoskeleton organization-ISS-  
GO:0030199collagen fibril organization-IEA-  
GO:0032963collagen metabolic process-IMP15102077  
GO:0048251elastic fiber assembly-IMP15102077  
GO ID GO Term Qualifier Evidence PubMed
GO:0005576extracellular region-HDA27068509  
GO:0005583fibrillar collagen trimercolocalizes_withIDA16278880  
GO:0005615extracellular space-HDA20551380  
GO:0005622intracellular-IDA15102077  
GO:0031012extracellular matrix-NAS7686164  
GO:0062023collagen-containing extracellular matrix-HDA27559042  
GO:0062023collagen-containing extracellular matrixcolocalizes_withHDA20551380  
GO:0062023collagen-containing extracellular matrixcolocalizes_withISS22261194  
GO:0070062extracellular exosome-HDA23533145  
KEGG ID KEGG Term
hsa04510Focal adhesion
hsa04512ECM-receptor interaction
Reactome ID Reactome Term Evidence
R-HSA-1474244Extracellular matrix organizationTAS
R-HSA-3000178ECM proteoglycansTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
28791728Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study. (2017 Nov)Barrow TMJ Pathol
28114305Targeted Sequencing of Lung Function Loci in Chronic Obstructive Pulmonary Disease Cases and Controls. (2017)Artigas MSPLoS One